Cite

HARVARD Citation

    Nijman, H. et al. (n.d.). P53, A TARGET ANTIGEN FOR IMMUNOTHERAPY IN OVARIAN CANCER - FROM PRECLINIC TO CLINIC. International journal of gynecological cancer. 13 (1), p. 44. [Online]. 
  
Back to record